- Home
- CGAU vs MMSI Comparison
CGAU vs MMSI Comparison
Compare CGAU & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGAU | MMSI |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.0B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CGAU | MMSI |
|---|---|---|
| Price | $17.45 | $64.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $16.67 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 1.4M | 502.5K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $25.17 | $8.85 |
| Revenue Next Year | $13.62 | $5.88 |
| P/E Ratio | ★ $11.74 | $31.34 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $6.31 | $65.96 |
| 52 Week High | $21.17 | $99.26 |
Technical Indicators
Market Signals| Indicator | CGAU | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 33.20 |
| Support Level | $16.43 | N/A |
| Resistance Level | $20.18 | $71.68 |
| Average True Range (ATR) | 0.70 | 1.92 |
| MACD | -0.19 | -0.21 |
| Stochastic Oscillator | 0.36 | 14.28 |
Price Performance
Historical ComparisonAbout CGAU Centerra Gold Inc.
Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.